Publications

  1. Lieske JC, Rule AD, Krambeck AE, Williams JC, Bergstralh EJ, Mehta RA, Moyer TP. Stone Composition as a Function of Age and Sex. Clin J Am Soc Nephrol. 2014 Oct 02.
    View PubMed
  2. Morbeck DE, Paczkowski M, Fredrickson JR, Krisher RL, Hoff HS, Baumann NA, Moyer T, Matern D. Composition of protein supplements used for human embryo culture. J Assist Reprod Genet. 2014 Sep 27.
    View PubMed
  3. Morbeck DE, Krisher RL, Herrick JR, Baumann NA, Matern D, Moyer T. Composition of commercial media used for human embryo culture. Fertil Steril. 2014 Sep; 102(3):759-766.e9. Epub 2014 Jul 04.
    View PubMed
  4. Estey MP, Diamandis EP, Van Der Straeten C, Tower SS, Hart AJ, Moyer TP. Cobalt and chromium measurement in patients with metal hip prostheses. Clin Chem. 2013 Jun; 59(6):880-6. Epub 2012 Oct 31
    View PubMed
  5. Coats D, Shelton-Dodge K, Ou K, Khun V, Seab S, Sok K, Prou C, Tortorelli S, Moyer TP, Cooper LE, Begley TP, Enders F, Fischer PR, Topazian M. Thiamine deficiency in Cambodian infants with and without beriberi. J Pediatr. 2012 Nov; 161(5):843-7. Epub 2012 Jun 14.
    View PubMed
  6. Schmitt BH, Feder MT, Rokke DL, Moyer TP, Pritt BS. An unusual foreign body in the urinary bladder mimicking a parasitic worm. J Clin Microbiol. 2012 Jul; 50(7):2520-2. Epub 2012 Apr 25
    View PubMed
  7. Moyer TP, Highsmith WE, Smyrk TC, Gross JB Jr. Hereditary hemochromatosis: laboratory evaluation. Clin Chim Acta. 2011 Aug 17; 412(17-18):1485-92. Epub 2011 Apr 13.
    View PubMed
  8. Wermers RA, Cooper K, Razonable RR, Deziel PJ, Whitford GM, Kremers WK, Moyer TP. Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy. Clin Infect Dis. 2011 Mar 1; 52(5):604-11. Epub 2011 Jan 16.
    View PubMed
  9. McAlpine DE, Biernacka JM, Mrazek DA, O'Kane DJ, Stevens SR, Langman LJ, Courson VL, Bhagia J, Moyer TP. Effect of cytochrome P450 enzyme polymorphisms on pharmacokinetics of venlafaxine. Ther Drug Monit. 2011 Feb; 33(1):14-20.
    View PubMed
  10. Christensen KN, Lee CU, Hanley MM, Leung N, Moyer TP, Pittelkow MR. Quantification of gadolinium in fresh skin and serum samples from patients with nephrogenic systemic fibrosis. J Am Acad Dermatol. 2011 Jan; 64(1):91-6. Epub 2010 Oct 30.
    View PubMed
  11. Epstein RS, Moyer TP, Aubert RE, O Kane DJ, Xia F, Verbrugge RR, Gage BF, Teagarden JR. Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study). J Am Coll Cardiol. 2010 Jun 22; 55(25):2804-12. Epub 2010 Apr 08.
    View PubMed
  12. Moyer TP, O'Kane DJ, Baudhuin LM, Wiley CL, Fortini A, Fisher PK, Dupras DM, Chaudhry R, Thapa P, Zinsmeister AR, Heit JA. Warfarin sensitivity genotyping: a review of the literature and summary of patient experience. Mayo Clin Proc. 2009 Dec; 84(12):1079-94.
    View PubMed
  13. Leung N, Pittelkow MR, Lee CU, Good JA, Hanley MM, Moyer TP. Chelation of gadolinium with deferoxamine in a patient with nephrogenic systemic fibrosis. Nephrology Dialysis Transplantation (NDT Plus) 2009; 2:309-11.
  14. Wilkins BW, Hesse C, Charkoudian N, Nicholson WT, Sviggum HP, Moyer TP, Joyner MJ, Eisenach JH. Autonomic cardiovascular control during a novel pharmacologic alternative to ganglionic blockade. Clin Pharmacol Ther. 2008 May; 83(5):692-701. Epub 2007 Aug 08.
    View PubMed
  15. Ebbert JO, Post JA, Moyer TP, Dale LC, Schroeder DR, Hurt RD. Nicotine percentage replacement among smokeless tobacco users with nicotine patch. Drug Alcohol Depend. 2007 Jul 10; 89(2-3):223-6. Epub 2007 Feb 14.
    View PubMed
  16. Wilkins BW, Hesse C, Sviggum HP, Nicholson WT, Moyer TP, Joyner MJ, Eisenach JH. Alternative to ganglionic blockade with anticholinergic and alpha-2 receptor agents. Clin Auton Res. 2007 Apr; 17(2):77-84. Epub 2006 Dec 11.
    View PubMed
  17. Ebbert JO, Dale LC, Patten CA, Croghan IT, Schroeder DR, Moyer TP, Hurt RD. Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users. Nicotine Tob Res. 2007 Jan; 9(1):43-52.
    View PubMed
  18. Woodworth A, Saunders AN, Koenig JW, Moyer TP, Turk J, Dietzen DJ. Differentiation of amphetamine/methamphetamine and other cross-immunoreactive sympathomimetic amines in urine samples by serial dilution testing. Clin Chem. 2006 Apr; 52(4):743-6. Epub 2006 Feb 02.
    View PubMed
  19. Renner CC, Enoch C, Patten CA, Ebbert JO, Hurt RD, Moyer TP, Provost EM. Iqmik: A form of smokeless tobacco used among Alaska Natives. Am J Health Behav. 2005 Nov-Dec; 29(6):588-94.
    View PubMed
  20. Hurt RD, Renner CC, Patten CA, Ebbert JO, Offord KP, Schroeder DR, Enoch CC, Gill L, Angstman SE, Moyer TP. Iqmik--a form of smokeless tobacco used by pregnant Alaska natives: nicotine exposure in their neonates. J Matern Fetal Neonatal Med. 2005 Apr; 17(4):281-9.
    View PubMed
  21. Butensky E, Fischer R, Hudes M, Schumacher L, Williams R, Moyer TP, Vichinsky E, Harmatz P. Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosis. Am J Clin Pathol. 2005 Jan; 123(1):146-52.
    View PubMed
  22. Ebbert JO, Dale LC, Nirelli LM, Schroeder DR, Moyer TP, Hurt RD. Cotinine as a biomarker of systemic nicotine exposure in spit tobacco users. Addict Behav. 2004 Feb; 29(2):349-55.
    View PubMed
  23. Wu AHB, McKay C, Broussard LA, Hoffman RS, Kwong TC, Moyer TP, Otten EM, Welch SL, Wax P. National academy of clinical biochemistry laboratory medicine practice guidelines: Recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. Clin Chem. 2003 Mar; 49(3):357-79.
    View PubMed
  24. Moyer TP, Charlson JR, Enger RJ, Dale LC, Ebbert JO, Schroeder DR, Hurt RD. Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. Clin Chem. 2002 Sep; 48(9):1460-71.
    View PubMed
  25. Schroeder DR, Ogburn PL Jr, Hurt RD, Croghan IT, Ramin KD, Offord KP, Moyer TP. Nicotine patch use in pregnant smokers: smoking abstinence and delivery outcomes. J Matern Fetal Neonatal Med. 2002 Feb; 11(2):100-7.
    View PubMed
  26. Roberts WL, Annesley TM, De BK, Moulton L, Juenke JM, Moyer TP. Performance characteristics of four free phenytoin immunoassays. Ther Drug Monit. 2001 Apr; 23(2):148-54.
    View PubMed
  27. Ogburn P, Ramin K, Schroeder D, Hurt R, Croghan I, Offord K, Moyer T. Long term nicotine patch use in pregnancy: safety and effectiveness. Am J Obstet Gynecol. 2001; 185(6):S120.
  28. Clouse WD, Yamaguchi H, Phillips MR, Hurt RD, Fitzpatrick LA, Moyer TP, Rowland C, Schaff HV, Miller VM. Effects of transdermal nicotine treatment on structure and function of coronary artery bypass grafts. J Appl Physiol (1985). 2000 Sep; 89(3):1213-23.
    View PubMed
  29. Harmatz P, Butensky E, Quirolo K, Williams R, Ferrell L, Moyer T, Golden D, Neumayr L, Vichinsky E. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood. 2000 Jul 1; 96(1):76-9.
    View PubMed
  30. Hurt RD, Ahlskog JE, Croghan GA, Offord KP, Wolter TD, Croghan IT, Moyer TP. Carbidopa/levodopa for smoking cessation: a pilot study with negative results. Nicotine Tob Res. 2000 Feb; 2(1):71-8.
    View PubMed
  31. Ogburn PL Jr, Hurt RD, Croghan IT, Schroeder DR, Ramin KD, Offord KP, Moyer TP. Nicotine patch use in pregnant smokers: nicotine and cotinine levels and fetal effects. Am J Obstet Gynecol. 1999 Sep; 181(3):736-43.
    View PubMed
  32. Moyer TP, Temesgen Z, Enger R, Estes L, Charlson J, Oliver L, Wright A. Drug monitoring of antiretroviral therapy for HIV-1 infection: method validation and results of a pilot study. Clin Chem. 1999 Sep; 45(9):1465-76.
    View PubMed
  33. Nixon DE, Burritt MF, Moyer TP. The determination of mercury in whole blood and urine by inductively coupled plasma mass spectrometry. Spectrochim Acta B. 1999 Aug 9; 54(8):1141-53.
  34. Nixon DE, Moyer TP, Burritt MF. The determination of selenium in serum and urine by inductively coupled plasma mass spectrometry: comparison with Zeeman graphite furnace atomic absorption spectrometry. Spectrochim Acta B. 1999 Jun 14; 54(6):931-42.
  35. Pettersen MD, Driscoll DJ, Moyer TP, Dearani JA, McGregor CG. Measurement of blood serum cyclosporine levels using capillary "fingerstick" sampling: a validation study. Transpl Int. 1999; 12(6):429-32.
    View PubMed
  36. Hurt RD, Offord KP, Croghan IT, Croghan GA, Gomez-Dahl LC, Wolter TD, Dale LC, Moyer TP. Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms. Psychopharmacology (Berl) 1998 Nov; 140(1):98-104.
    View PubMed
  37. Weinzweig J, Schnur PL, McConnell JP, Harris JB, Petty PM, Moyer TP, Nixon D. Silicon analysis of breast and capsular tissue from patients with saline or silicone gel breast implants: II. Correlation with connective-tissue disease. Plastic & Reconstructive Surgery. 1998 Jun; 101(7):1836-41.
    View PubMed
  38. Moyer TP, Oliver LK. Supporting pharmaceutical studies for FDA submissions: diversifying the drug monitoring laboratory. Clin Chem. 1998 Feb; 44(2):433-6.
    View PubMed
  39. Ludwig J, Hashimoto E, Porayko MK, Moyer TP, Baldus WP. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology. 1997 Mar; 112(3):882-8.
    View PubMed
  40. McConnell JP, Moyer TP, Nixon DE, Schnur PL, Salomao DR, Crotty TB, Weinzweig J, Harris JB, Petty PM. Determination of silicon in breast and capsular tissue from patients with breast implants performed by inductively coupled plasma emission spectroscopy. Comparison with tissue histology. Am J Clin Pathol. 1997 Feb; 107(2):236-46.
    View PubMed
  41. Schnur PL, Weinzweig J, Harris JB, Moyer TP, Petty PM, Nixon D, McConnell JP. Silicon analysis of breast and periprosthetic capsular tissue from patients with saline or silicone gel breast implants. Plast Reconstr Surg. 1996 Oct; 98(5):798-803.
    View PubMed
  42. Nixon DE, Moyer TP. Routine clinical determination of lead, arsenic, cadmium, and thallium in urine and whole blood by inductively coupled plasma mass spectrometry. Spectrochim Acta B. 1996 Jan 15; 51(1):13-25.
  43. Fleming CR, George L, Stoner GL, Tarrosa VB, Moyer TP. The importance of urinary magnesium values in patients with gut failure. Mayo Clin Proc. 1996 Jan; 71(1):21-4.
    View PubMed
  44. Nixon DE, Mussmann GV, Moyer TP. Inorganic, organic, and total mercury in blood and urine: cold vapor analysis with automated flow injection sample delivery. J Anal Toxicol. 1996 Jan-Feb; 20(1):17-22.
    View PubMed
  45. Ho J, Moyer TP, Phillips SF. Chronic diarrhea: the role of magnesium. Mayo Clin Proc. 1995 Nov; 70(11):1091-2.
    View PubMed
  46. Ahlskog JE, Waring SC, Kurland LT, Petersen RC, Moyer TP, Harmsen WS, Maraganore DM, O'Brien PC, Esteban-Santillan C, Bush V. Guamanian neurodegenerative disease: investigation of the calcium metabolism/heavy metal hypothesis. Neurology. 1995 Jul; 45(7):1340-4.
    View PubMed
  47. Alzaid AA, Dinneen SF, Moyer TP, Rizza RA. Effects of insulin on plasma magnesium in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab. 1995 Apr; 80(4):1376-81.
    View PubMed
  48. Bush VJ, Moyer TP, Batts KP, Parisi JE. Essential and toxic element concentrations in fresh and formalin-fixed human autopsy tissues. Clin Chem. 1995 Feb; 41(2):284-94.
    View PubMed
  49. Ludwig J, Moyer TP, Rakela J. The liver biopsy diagnosis of Wilson's disease. Methods in pathology. Am J Clin Pathol. 1994 Oct; 102(4):443-6.
    View PubMed
  50. Ludwig J, Batts KP, Moyer TP, Poterucha JJ. Advances in liver biopsy diagnosis. Mayo Clin Proc. 1994 Jul; 69(7):677-8.
    View PubMed
  51. Moyer TP. Testing for arsenic. Mayo Clin Proc. 1993 Dec; 68(12):1210-1.
    View PubMed
  52. Morgenstern BZ, Milliner DS, Murphy ME, Simmons PS, Moyer TP, Wilson DM, Smith LH. Urinary oxalate and glycolate excretion patterns in the first year of life: a longitudinal study. J Pediatr. 1993 Aug; 123(2):248-51.
    View PubMed
  53. Lieberman N, Plevak D, Moyer T, Rettke S, Raasch R, Southorn P. Is it important to measure magnesium concentrations during and immediately after liver transplantation? Transplant Proc. 1993 Apr; 25(2):1826-7.
    View PubMed
  54. Ludwig J, Batts KP, Moyer TP, Baldus WP, Fairbanks VF. Liver biopsy diagnosis of homozygous hemochromatosis: a diagnostic algorithm. Mayo Clin Proc. 1993 Mar; 68(3):263-7.
    View PubMed
  55. Herkes GK, Eadie MJ, Sharbrough FW, Moyer TP. Patterns of seizure occurrence in catamenial epilepsy. Epilepsy Research. 1993; 15:47-52.
    View PubMed
  56. Nixon DE, Moyer TP. Arsenic analysis II: rapid separation and quantification of inorganic arsenic plus metabolites and arsenobetaine from urine. Clin Chem. 1992 Dec; 38(12):2479-83.
    View PubMed
  57. Nixon DE, Mussmann GV, Eckdahl SJ, Moyer TP. Total arsenic in urine: palladium-persulfate vs nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry. Clin Chem. 1991 Sep; 37(9):1575-9.
    View PubMed
  58. Moyer TP, Winkels J, Krom R, Wiesner R. Evaluation of Abbott TDx monoclonal assay of cyclosporine in whole blood. Clin Chem. 1991 Jun; 37(6):1120-1.
    View PubMed
  59. Hayes SN, Moyer TP, Morley D, Bove AA. Intravenous cocaine causes epicardial coronary vasoconstriction in the intact dog. Am Heart J. 1991 Jun; 121(6 Pt 1):1639-48.
    View PubMed
  60. Moyer TP, Mussmann GV, Nixon DE. Blood-collection device for trace and ultra-trace metal specimens evaluated. Clin Chem. 1991 May; 37(5):709-14.
    View PubMed
  61. McCarthy JT, Hodgson SF, Fairbanks VF, Moyer TP. Clinical and histologic features of iron-related bone disease in dialysis patients. Am J Kidney Dis. 1991 May; 17(5):551-61.
    View PubMed
  62. Zachariah PK, Moyer TP, Theobald HM, Frantz RP, Kurtz SB, McCarthy JT, Smith RL. The pharmacokinetics of racemic verapamil in patients with impaired renal function. J Clin Pharmacol. 1991 Jan; 31(1):45-53.
    View PubMed
  63. Kachel DL, Moyer TP, Martin WJ 2nd. Amiodarone-induced injury of human pulmonary artery endothelial cells: protection by alpha-tocopherol. Journal of Pharmacology & Experimental Therapeutics. 1990 Sep; 254(3):1107-12.
    View PubMed
  64. Martin RW, Duffy J, Engel AG, Lie JT, Bowles CA, Moyer TP, Gleich GJ. The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. Ann Intern Med. 1990 Jul 15; 113(2):124-34.
    View PubMed
  65. Nelson PE, Moyer TP, Thistle JL. Gallstone dissolution in vitro using methyl tert-butyl ether: radiologic selection criteria. Gastroenterology. 1990 May; 98(5 Pt 1):1280-3.
    View PubMed
  66. Nelson PE, Moyer TP, Thistle JL. Dissolution of calcium bilirubinate and calcium carbonate debris remaining after methyl tert-butyl ether dissolution of cholesterol gallstones. Gastroenterology. 1990 May; 98(5 Pt 1):1345-50.
    View PubMed
  67. Moyer TP, et al. Consensus Document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine. Transplantation Proceedings. 1990; 22(3):1357-61.
    View PubMed
  68. Nixon DE, Moyer TP, Squillace DP, McCarthy JT. Determination of serum nickel by graphite furnace atomic absorption spectrometry with Zeeman-effect background correction: values in a normal population and a population undergoing dialysis. Analyst. 1989 Dec; 114(12):1671-4.
    View PubMed
  69. McCarthy JT, Johnson WJ, Nixon DE, Jenson BM, Moyer TP. Transfusional iron overload in patients undergoing dialysis: treatment with erythropoietin and phlebotomy. J Lab Clin Med. 1989 Aug; 114(2):193-9.
    View PubMed
  70. Welsh PW, O'Connell EJ, Sachs MI, Moyer TP, Wick KA, Harrison LI, McCarville SE, Kvam DC. Pharmacokinetic properties of sustained-release theophylline (Theolair-SR) in relation to timing of doses after low-fat meals. Ann Allergy. 1989 May; 62(5):396-400.
    View PubMed
  71. de Groen PC, McCallum DK, Moyer TP, Wiesner RH. Pharmacokinetics of cyclosporine in patients with primary biliary cirrhosis. Transplant Proc. 1988 Apr; 20(2 Suppl 2):509-11.
    View PubMed
  72. Moyer TP, Post GR, Sterioff S, Anderson CF. Cyclosporine nephrotoxicity is minimized by adjusting dosage on the basis of drug concentration in blood. Mayo Clin Proc. 1988 Mar; 63(3):241-7.
    View PubMed
  73. Fleischer JE, Milde JH, Moyer TP, Michenfelder JD. Cerebral effects of high-dose midazolam and subsequent reversal with Ro 15-1788 in dogs. Anesthesiology. 1988 Feb; 68(2):234-42.
    View PubMed
  74. Moyer TP, Palmen MA, Johnson P, Charlson JR, Ellefson PJ. Marijuana testing--how good is it? Mayo Clin Proc. 1987 May; 62(5):413-7.
    View PubMed
  75. Post GR, Moyer TP, Anderson CF, Sterioff S. Long-term cyclosporine for renal allograft patients does not cause nephrotoxicity. Transplant Proc. 1987 Feb; 19(1 Pt 2):1761-3.
    View PubMed
  76. National Academy of Clinical Biochemistry/ American Association for Clinical Chemistry Task Forceon Cyclosporine Monitoring. Critical issues in cyclosporine monitoring: Report of the task force on cyclosporine monitoring. Clin Chem. 1987; 33:1269-88.
  77. McCarthy JT, Milliner DS, Kurtz SB, Johnson WJ, Moyer TP. Interpretation of serum aluminum values in dialysis patients. Am J Clin Pathol. 1986 Nov; 86(5):629-36.
    View PubMed
  78. Nixon DE, Moyer TP, Johnson P, McCall JT, Ness AB, Fjerstad WH, Wehde MB. Routine measurement of calcium, magnesium, copper, zinc, and iron in urine and serum by inductively coupled plasma emission spectroscopy. Clin Chem. 1986 Sep; 32(9):1660-5.
    View PubMed
  79. Zachariah PK, Bloedow DC, Moyer TP, Sheps SG, Schirger A, Fealey RD. Pharmacodynamics of midodrine, an antihypotensive agent. Clinical Pharmacology & Therapeutics. 1986 May; 39(5):586-91.
    View PubMed
  80. Moyer TP, Johnson P, Faynor SM, Sterioff S. Cyclosporine: a review of drug monitoring problems and presentation of a simple, accurate liquid chromatographic procedure that solves these problems. Clin Biochem. 1986 Apr; 19(2):83-9.
    View PubMed
  81. Nixon DE, Moyer TP, Windebank AJ, Webster DD, Mussmann GV, McCall JT. Lack of correlation of low levels of whole blood and serum lead in humans. An experimental evaluation of this relationship in animals. Trace Substances in Environmental Health XIX: 1986; 248-256.
  82. Moyer TP, Charlson JR, Ebnet LE. Improved chromatography of cyclosporine. Ther Drug Monit. 1986; 8(4):466-8.
    View PubMed
  83. Sill JC, Nugent M, Moyer TP, Schaff H, Tinker JH. Plasma levels of beta-blocking drugs prior to coronary artery bypass surgery. Anesthesiology. 1985 Jan; 62(1):67-70.
    View PubMed
  84. Faynor SM, Moyer TP, Sterioff S, McDonald MW. Therapeutic drug monitoring of cyclosporine. Mayo Clin Proc. 1984 Aug; 59(8):571-2.
    View PubMed
  85. Nugent M, Tinker JH, Moyer TP. Verapamil worsens rate of development and hemodynamic effects of acute hyperkalemia in halothane-anesthetized dogs: effects of calcium therapy. Anesthesiology. 1984 May; 60(5):435-9.
    View PubMed
  86. Sill JC, Nugent M, Moyer TP, Torres LE, Schaff HV, Tinker JH. Influence of propranolol plasma levels on hemodynamics during coronary artery bypass surgery. Anesthesiology. 1984 May; 60(5):455-63.
    View PubMed
  87. Mastropaolo W, Holmes DR, Osborn MJ, Rooke J, Moyer TP. Improved liquid-chromatographic determination of mexiletine, an antiarrhythmic drug, in plasma. Clin Chem. 1984 Feb; 30(2):319-22.
    View PubMed
  88. Sedman AJ, Gal J, Mastropaolo W, Johnson P, Maloney JD, Moyer TP. Serum tocainide enantiomer concentrations in human subjects. Br J Clin Pharmacol. 1984 Jan; 17(1):113-5.
    View PubMed
  89. McGoon MD, Seward JB, Vlietstra RE, Choo MH, Moyer TP, Reeder GS. Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension. Br Heart J. 1983 Dec; 50(6):579-85.
    View PubMed
  90. Moyer TP, Maruta T, Richelson E, Richardson JW. The implications for antidepressant therapy of measurement of urinary MHPG. Mayo Clin Proc. 1982 Oct; 57(10):665-7.
    View PubMed
  91. Coulam CB, Moyer TP, Jiang NS, Zincke H. Breast-feeding after renal transplantation. Transplant Proc. 1982 Sep; 14(3):605-9.
    View PubMed
  92. Ducatman AM, Amundsen MA, Moyer TP. Case report: chronic nervous system disability-evaluation of the role of organophosphate pesticides. Am Assoc Clin Chem (Tdm - Therapeutic Drug Monitoring) 1982 Jul; 1-3.
  93. Welch CL, Annesley TM, Luthra HS, Moyer TP. Liquid-chromatographic determination of zomepirac in serum and plasma. Clin Chem. 1982 Mar; 28(3):481-4.
    View PubMed
  94. Yao JK, Dyck PJ, VanLoon JA, Moyer TP. Free fatty acid composition of human and rat peripheral nerve. J Neurochem. 1981 Mar; 36(3):1211-8.
    View PubMed
  95. Moertel CG, Ames MM, Kovach JS, Moyer TP, Rubin JR, Tinker JH. A pharmacologic and toxicological study of amygdalin. JAMA. 1981 Feb 13; 245(6):591-4.
    View PubMed
  96. Moyer TP, Sheps SG. Antihypertensive agents: role of therapeutic drug monitoring. Ther Drug Monit. 1981; 3(3):217-30.
    View PubMed
  97. Ames MM, Moyer TP, Kovach JS, Moertel CG, Rubin J. Pharmacology of amygdalin (laetrile) in cancer patients. Cancer Chemotherapy & Pharmacology. 1981; 6(1):51-7.
    View PubMed
  98. Tisdall PA, Moyer TP, Anhalt JP. Liquid-chromatographic detection of thiazide diuretics in urine. Clin Chem. 1980 May; 26(6):702-6.
    View PubMed
  99. Stote RM, Smith LH, Dubb JW, Moyer TP, Alexander F, Roth JL. Oxypurinol nephrolithiasis in regional enteritis secondary to allopurinol therapy. Ann Intern Med. 1980 Mar; 92(3):384-5.
    View PubMed
  100. Anhalt JP, Moyer TP. The role of gas-liquid chromatography and liquid chromatography in therapeutic drug monitoring. Laboratory Medicine. 1980; 11:797-806.
  101. Moyer TP, Fischer AG, Schulz AR. Kinetic studies on bovine thyroidal purine nucleoside phosphorylase. Int J Biochem. 1980; 11(3-4):243-50.
    View PubMed
  102. Moyer TP, Jiang NS, Tyce GM, Sheps SG. Analysis for urinary catecholamines by liquid chromatography with amperometric detection: methodology and clinical interpretation of results. Clin Chem. 1979 Feb; 25(2):256-63.
    View PubMed
  103. Muldoon SM, Tyce GM, Moyer TP, Rorie DK. Measurement of endogenous norepinephrine overflow from saphenous veins. Am J Physiol. 1979 Feb; 236:H263-H267.
    View PubMed
  104. Moyer TP, Carpenter PC, Jiang NS, Machacek D. Series on clinical testing. 2. Fractionation of urinary ketosteroids: procedure and clinical significance. Mayo Clin Proc. 1978 Sep; 53:601-606.
    View PubMed
  105. Moyer TP, Jiang NS. Optimized isocratic conditions for analysis of catecholamines by high-performance reversed-phase paired-ion chromatography with amperometric detection. J Chromatogr. 1978 Jul 3; 153:365-372.
  106. Lee H, Carlson JD, McMahon KK, Moyer TP, Fischer AG. Xanthine oxidase: a source of hydrogen peroxide in bovine thyroid glands. Life Sci. 1977 Feb 1; 20(3):453-8.
    View PubMed
  107. Moyer TP, Fischer AG. Purification and characterization of a purine-nucleoside phosphorylase from bovine thyroid. Arch Biochem Biophys. 1976 Jun; 174(2):622-9.
    View PubMed